Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery.
Servando Hernandez VargasSusanne KossatzJulie VossSukhen C GhoshHop S Tran CaoJo SimienThomas ReinerSadhna DhingraWilliam E FisherAli AzhdariniaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
The radioactive utility of the MMC allowed us to validate the binding properties of a novel FGS agent that could have a broad impact on cancer outcomes by equipping surgeons with real-time intraoperative imaging capabilities.
Keyphrases
- papillary thyroid
- minimally invasive
- high resolution
- coronary artery bypass
- squamous cell
- quality improvement
- binding protein
- single molecule
- cancer therapy
- patients undergoing
- surgical site infection
- lymph node metastasis
- squamous cell carcinoma
- energy transfer
- neuroendocrine tumors
- dna binding
- mass spectrometry
- fluorescence imaging
- young adults
- acute coronary syndrome
- atrial fibrillation
- glycemic control